JoVE Logo
Faculty Resource Center

Sign In

High Content Screening in Neurodegenerative Diseases

DOI :

10.3791/3452-v

13:32 min

January 6th, 2012

January 6th, 2012

17,065 Views

1Department of Clinical Genetics, VU University Medical Center, 2Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam

We describe a methodology combining automated cell culturing with high-content imaging to visualize and quantify multiple cellular processes and structures, in a high-throughput manner. Such methods can aid in the further functional annotation of genomes as well as identify disease gene networks and potential drug targets.

Tags

High Content Screening

-- Views

Related Videos

article

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

article

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

article

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

article

In vivo 19F MRI for Cell Tracking

article

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

article

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

article

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

article

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

article

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

article

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved